Arena BioWorks
Bridget Wagner leads research groups in identifying small molecules for diabetes therapy at Arena BioWorks and has a background in biochemistry from Harvard University. Prior to their current role, Bridget held various positions at the Broad Institute of MIT and Harvard, focusing on pancreatic cell biology and chemical biology.
This person is not in any teams
Arena BioWorks
Arena BioWorks is a biomedical research institute focused on uncovering the mechanisms of human disease to identify opportunities for therapeutic intervention. The Institute's private funding model allows Arena to advance novel therapeutics by forming and supporting biotech companies up to early clinical / Series B stage. To learn more, visit arenabioworks.com.